Open Access 01-12-2019 | Migraine | Research article
An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: the REPOSE study
Published in: The Journal of Headache and Pain | Issue 1/2019
Login to get access